Valley National Advisers’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-24,722
Closed -$77K 1023
2021
Q4
$77K Hold
24,722
0.01% 311
2021
Q3
$89K Hold
24,722
0.02% 294
2021
Q2
$89K Buy
24,722
+3,271
+15% +$11.5K 0.02% 292
2021
Q1
$84K Buy
21,451
+327
+2% +$1.35K 0.02% 292
2020
Q4
$89K Buy
21,124
+2,786
+15% +$10.7K 0.02% 267
2020
Q3
$68K Hold
18,338
0.02% 264
2020
Q2
$80K Hold
18,338
0.02% 243
2020
Q1
$70K Buy
18,338
+3,050
+20% +$15K 0.02% 248
2019
Q4
$97K Sell
15,288
-1,100
-7% -$6.47K 0.02% 250
2019
Q3
$69K Hold
16,388
0.02% 270
2019
Q2
$76K Hold
16,388
0.02% 257
2019
Q1
$87K Hold
16,388
0.02% 246
2018
Q4
$61K Sell
16,388
-6,327
-28% -$22.2K 0.02% 253
2018
Q3
$64K Sell
22,715
-15,000
-40% -$42.1K 0.02% 239
2018
Q2
$111K Hold
37,715
0.04% 207
2018
Q1
$85K Hold
37,715
0.03% 215
2017
Q4
$111K Hold
37,715
0.04% 197
2017
Q3
$111K Hold
37,715
0.04% 192
2017
Q2
$106K Buy
37,715
+14,000
+59% +$29.5K 0.04% 192
2017
Q1
$45K Buy
23,715
+19,500
+463% +$37.6K 0.02% 249
2016
Q4
$7K Sell
4,215
-4,200
-50% -$8.58K ﹤0.01% 458
2016
Q3
$23K Hold
8,415
0.01% 292
2016
Q2
$20K Buy
8,415
+1,750
+26% +$4.83K 0.01% 311
2016
Q1
$22K Buy
6,665
+665
+11% +$2.46K 0.01% 300
2015
Q4
$29K Sell
6,000
-565
-9% -$3.2K 0.02% 262
2015
Q3
$37K Hold
6,565
0.02% 248
2015
Q2
$52K Buy
6,565
+1,500
+30% +$12.9K 0.03% 227
2015
Q1
$53K Buy
+5,065
New +$69.2K 0.03% 217

Other funds holding BDSI

Valley National Advisers's BDSI Position: Q1 2022 in Review

Valley National Advisers sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 24,722 shares — an estimated $77K sold.

Valley National Advisers first reported a position in BDSI in Q1 2015 and held it in 28 quarters. The position peaked at $111K in Q2 2018. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Valley National Advisers reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Valley National Advisers sold 24,722 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $77K.
  • Valley National Advisers first reported a position in BioDelivery Sciences International, Inc. in Q1 2015 and held it in 28 quarters.
  • Valley National Advisers's BioDelivery Sciences International, Inc. position peaked at $111K in Q2 2018.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Valley National Advisers's 13F filing for Q1 2022, filed 6 May 2022.